Skip to main content
    D

    DarioHealth Corp (DRIO)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $1.15
    -0.11 (-8.73%)

    Market Cap: $14.22M

    Last updated: Nov 17, 2026 at 10:57 AM ET

    DarioHealth Corp (DRIO) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    DarioHealth (DRIO) trades at 0.7x sales and 0.2x book value. Its P/S of 0.7x is below its 5-year median of 3.0x. Its forward P/E is 10.6x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/E10.6x
    Price to sales0.7x
    Price to book0.2x
    PEGN/A
    FCF yield-170.6%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 79.4% below 3.4x and its P/B is 93.5% below 3.1x.

    MultipleCurrent5-year median10-year median
    P/S0.7x3.0x3.4x
    P/B0.2x1.1x3.1x
    Medians of month-end values through Oct 2026: 52 to 60 months (5-year) and 101 to 115 months (10-year).

    Valuation History

    Over the 8 of the 10 year ends shown that have a P/S, its P/S ranged from 1.7x in 2025 to 18.3x in 2021. 2025 was the lowest of those years.

    Year endPriceP/SP/B
    2025$11.381.7x8.3x
    2024$15.72N/A0.4x
    2023$34.402.9x16.1x
    2022$85.604.3x27.5x
    2021$259.4018.3x47.6x
    2020$285.80N/A3.7x
    2019$131.203.2x4.3x
    2018$310.403.4x63.9x
    2017$640.803.1x6.1x
    2016$1,300.006.3xN/A
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    Frequently Asked Questions About DRIO

    What is DRIO's forward P/E ratio?

    DarioHealth has a forward P/E ratio of 10.6x.

    What is DRIO's price to sales ratio?

    DarioHealth has a price to sales ratio of 0.7x.